Alzheimer’s Digital Therapeutic to Unlock the Power of Music TherapyTORONTO (BUSINESS WIRE) 12.7 million Americans aged 65 and older are projected to have Alzheimer’s dementia by 2050. LUCID and JT are now partnering on the development of a prescription digital therapeutic for Alzheimer’s disease.Alzheimer’s is mo.
Biogen struck a deal that could bring a digital therapeutic to its multiple sclerosis product portfolio. The drugmaker is partnering with startup MedRhythms in the development of a therapy that combines sensors, software, and music to improve walking problems in multiple sclerosis patients.